154 related articles for article (PubMed ID: 37906371)
1. Clustering of gout-related comorbidities and their relationship with gout flares: a data-driven cluster analysis of eight comorbidities.
Liu S; Sun H; Yang S; Liang N; Gao Y; Qu S; Chen H
J Endocrinol Invest; 2024 May; 47(5):1119-1128. PubMed ID: 37906371
[TBL] [Abstract][Full Text] [Related]
2. Onset of comorbidities and flare patterns within pre-existing morbidity clusters in people with gout: 5-year primary care cohort study.
Bajpai R; Muller S; Mallen C; Watson L; Richette P; Hider SL; Roddy E
Rheumatology (Oxford); 2021 Dec; 61(1):407-412. PubMed ID: 33744931
[TBL] [Abstract][Full Text] [Related]
3. Revisiting comorbidities in gout: a cluster analysis.
Richette P; Clerson P; Périssin L; Flipo RM; Bardin T
Ann Rheum Dis; 2015 Jan; 74(1):142-7. PubMed ID: 24107981
[TBL] [Abstract][Full Text] [Related]
4. Comorbidity clusters in people with gout: an observational cohort study with linked medical record review.
Bevis M; Blagojevic-Bucknall M; Mallen C; Hider S; Roddy E
Rheumatology (Oxford); 2018 Aug; 57(8):1358-1363. PubMed ID: 29672754
[TBL] [Abstract][Full Text] [Related]
5. The absolute risk of gout by clusters of gout-associated comorbidities and lifestyle factors-30 years follow-up of the Malmö Preventive Project.
Fatima T; Nilsson PM; Turesson C; Dehlin M; Dalbeth N; Jacobsson LTH; Kapetanovic MC
Arthritis Res Ther; 2020 Oct; 22(1):244. PubMed ID: 33066806
[TBL] [Abstract][Full Text] [Related]
6. Asymptomatic Hyperuricemia Without Comorbidities Predicts Cardiometabolic Diseases: Five-Year Japanese Cohort Study.
Kuwabara M; Niwa K; Hisatome I; Nakagawa T; Roncal-Jimenez CA; Andres-Hernando A; Bjornstad P; Jensen T; Sato Y; Milagres T; Garcia G; Ohno M; Lanaspa MA; Johnson RJ
Hypertension; 2017 Jun; 69(6):1036-1044. PubMed ID: 28396536
[TBL] [Abstract][Full Text] [Related]
7. Tophi and frequent gout flares are associated with impairments to quality of life, productivity, and increased healthcare resource use: Results from a cross-sectional survey.
Khanna PP; Nuki G; Bardin T; Tausche AK; Forsythe A; Goren A; Vietri J; Khanna D
Health Qual Life Outcomes; 2012 Sep; 10():117. PubMed ID: 22999027
[TBL] [Abstract][Full Text] [Related]
8. Gout treatment and comorbidities: a retrospective cohort study in a large US managed care population.
Primatesta P; Plana E; Rothenbacher D
BMC Musculoskelet Disord; 2011 May; 12():103. PubMed ID: 21599917
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular Disease and Gout: Real-World Experience Evaluating Patient Characteristics, Treatment Patterns, and Health Care Utilization.
Pillinger MH; Bangalore S; Klein AB; Baumgartner S; Morlock R
J Manag Care Spec Pharm; 2017 Jun; 23(6):677-683. PubMed ID: 28530520
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of febuxostat in 73 gouty patients with stage 4/5 chronic kidney disease: A retrospective study of 10 centers.
Juge PA; Truchetet ME; Pillebout E; Ottaviani S; Vigneau C; Loustau C; Cornec D; Pascart T; Snanoudj R; Bailly F; Cornec-Le Gall E; Schaeverbeke T; Saraux A; Dieudé P; Flipo RM; Richette P; Lioté F; Bardin T; Chalès G; Ea HK
Joint Bone Spine; 2017 Oct; 84(5):595-598. PubMed ID: 27825577
[TBL] [Abstract][Full Text] [Related]
11. Association between serum urate, gout and comorbidities: a case-control study using data from the UK Biobank.
Sandoval-Plata G; Nakafero G; Chakravorty M; Morgan K; Abhishek A
Rheumatology (Oxford); 2021 Jul; 60(7):3243-3251. PubMed ID: 33313843
[TBL] [Abstract][Full Text] [Related]
12. Frequency and risk factors of gout flares in a large population-based cohort of incident gout.
Rothenbacher D; Primatesta P; Ferreira A; Cea-Soriano L; Rodríguez LA
Rheumatology (Oxford); 2011 May; 50(5):973-81. PubMed ID: 21228059
[TBL] [Abstract][Full Text] [Related]
13. Cohort study investigating gout flares and management in UK general practice.
Finnikin S; Mallen CD; Roddy E
BMC Prim Care; 2023 Nov; 24(1):246. PubMed ID: 37993770
[TBL] [Abstract][Full Text] [Related]
14. Clustering Patients With Gout Based on Comorbidities and Biomarkers: A Cross-Sectional Study.
Alduraibi FK; Saleem M; Ricart K; Patel RP; Szalai AJ; Singh JA
J Rheumatol; 2023 Jun; 50(6):817-826. PubMed ID: 36521917
[TBL] [Abstract][Full Text] [Related]
15. Renal flare as a predictor of incident and progressive CKD in patients with lupus nephritis.
Parikh SV; Nagaraja HN; Hebert L; Rovin BH
Clin J Am Soc Nephrol; 2014 Feb; 9(2):279-84. PubMed ID: 24262502
[TBL] [Abstract][Full Text] [Related]
16. Association Between Gout Flare and Subsequent Cardiovascular Events Among Patients With Gout.
Cipolletta E; Tata LJ; Nakafero G; Avery AJ; Mamas MA; Abhishek A
JAMA; 2022 Aug; 328(5):440-450. PubMed ID: 35916846
[TBL] [Abstract][Full Text] [Related]
17. Urate-lowering Therapy and Chronic Kidney Disease Development in Patients with Gout.
Yen FS; Wei JC; Chang CL; Yang CC; Hsu CC; Hwu CM
Int J Med Sci; 2021; 18(12):2599-2606. PubMed ID: 34104091
[No Abstract] [Full Text] [Related]
18. One- and 2-year flare rates after treat-to-target and tight-control therapy of gout: results from the NOR-Gout study.
Uhlig T; Karoliussen LF; Sexton J; Kvien TK; Haavardsholm EA; Perez-Ruiz F; Hammer HB
Arthritis Res Ther; 2022 Apr; 24(1):88. PubMed ID: 35443675
[TBL] [Abstract][Full Text] [Related]
19. Gout epidemiology and comorbidities.
Singh JA; Gaffo A
Semin Arthritis Rheum; 2020 Jun; 50(3S):S11-S16. PubMed ID: 32620196
[TBL] [Abstract][Full Text] [Related]
20. Gout is associated with a higher risk of chronic renal disease in older adults: a retrospective cohort study of U.S. Medicare population.
Singh JA; Cleveland JD
BMC Nephrol; 2019 Mar; 20(1):93. PubMed ID: 30876398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]